Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Tax Provisions (2016 - 2024)

Arcadia Biosciences filings provide 11 years of Tax Provisions readings, the most recent being $8000.0 for Q4 2024.

  • On a quarterly basis, Tax Provisions rose 14.29% to $8000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $15000.0, a 28.57% decrease, with the full-year FY2025 number at $8000.0, changed 0.0% from a year prior.
  • Tax Provisions hit $8000.0 in Q4 2024 for Arcadia Biosciences, up from $7000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $17000.0 in Q1 2020 to a low of -$139000.0 in Q4 2020.
  • Median Tax Provisions over the past 5 years was $1000.0 (2021), compared with a mean of -$8272.7.
  • Biggest five-year swings in Tax Provisions: tumbled 1058.33% in 2020 and later surged 1200.0% in 2022.
  • Arcadia Biosciences' Tax Provisions stood at -$139000.0 in 2020, then surged by 100.72% to $1000.0 in 2021, then surged by 1200.0% to $13000.0 in 2022, then tumbled by 46.15% to $7000.0 in 2023, then grew by 14.29% to $8000.0 in 2024.
  • The last three reported values for Tax Provisions were $8000.0 (Q4 2024), $7000.0 (Q4 2023), and $1000.0 (Q2 2023) per Business Quant data.